ITI-012

N/A

Report date: 2023/08/28 11:23:15
NME

Base Information

Drug NameITI-012
Drug Alias NameITI-012 seriesITI-012
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCasein kinase I inhibitors
TargetsCasein kinase I
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIntra-Cellular Therapies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIntra-Cellular Therapies Inc
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A